Karo Healthcare announces the acquisition of the rights to the global OTC brand Lamisil® from Haleon UK Holdings Ltd. for a total consideration of GBP 235m (EUR 274m).
Source: Karo Healthcare
Karo Healthcare announces the acquisition of the rights to the global OTC brand Lamisil® from Haleon UK Holdings Ltd. for a total consideration of GBP 235m (EUR 274m).
Source: Karo Healthcare